Prediction of chronic lymphocytic leukaemia incidence in Germany and of patients ineligible for standard chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prediction of chronic lymphocytic leukaemia incidence in Germany and of patients ineligible for standard chemotherapy

Published:2015-03-11 Issue:2 Volume:34 Page:93-101
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol Oncol

Author:

Eisemann Nora¹,Schnoor Maike²,Katalinic Alexander¹

Affiliation:

1. Institute of Cancer Epidemiology; University of Luebeck; Luebeck Germany

2. Institute of Social Medicine and Epidemiology; University of Luebeck; Luebeck Germany

Funder

Roche

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference35 articles.

1. Alemtuzumab for patients with chronic lymphocytic leukaemia;Skoetz;The Cochrane database of Syst Rev,2012

2. B-cell chronic lymphocytic leukemia: recent progress in biology, diagnosis, and therapy;Montserrat;Ann Oncol,1997

3. Front-line therapy for chronic lymphocytic leukemia;Desai;Cancer Control,2012

4. A clinical staging system for chronic lymphocytic leukemia: prognostic significance;Binet;Cancer,1977

5. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis;Binet;Cancer,1981

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP